Insulet (PODD) Other Non-Current Liabilities (2010 - 2026)
Insulet's (PODD) quarterly Other Non-Current Liabilities came in at $67.7 million in Q1 2026, up 25.6% YoY from $53.9 million in Q1 2025, and up 5.12% on a QoQ basis from $64.4 million in Q4 2025.
Insulet (PODD) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Other Non-Current Liabilities data on file, last reported at $67.7 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 25.6% year-over-year to $67.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.7 million (up 25.6% YoY) and the FY2025 annual result came in at $64.4 million, up 24.56% from the prior year.
- Other Non-Current Liabilities rose to $67.7 million in Q1 2026, from $64.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $67.7 million in Q1 2026 to a low of $17.0 million in Q1 2022.
- A 5-year average of $43.0 million and a median of $38.3 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 139.6% in 2022, down 3.95% in 2022.
- Tracing PODD's Other Non-Current Liabilities over 5 years: stood at $35.7 million in 2022, then rose by 6.16% to $37.9 million in 2023, then jumped by 36.41% to $51.7 million in 2024, then climbed by 24.56% to $64.4 million in 2025, then gained by 5.12% to $67.7 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $67.7 million (Q1 2026), $64.4 million (Q4 2025), and $62.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Insulet | 10.35 Bn | 9.82 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.20 Mn |
| Mar 31, 2026 | 67.70 Mn |
| Dec 31, 2025 | 64.40 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Jun 30, 2025 | 57.10 Mn |
| Mar 31, 2025 | 53.90 Mn |
| Dec 31, 2024 | 51.70 Mn |
| Sep 30, 2024 | 44.90 Mn |
| Jun 30, 2024 | 37.30 Mn |
| Mar 31, 2024 | 38.30 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Sep 30, 2023 | 38.20 Mn |
| Jun 30, 2023 | 38.30 Mn |
| Mar 31, 2023 | 34.20 Mn |
| Dec 31, 2022 | 35.70 Mn |
| Sep 30, 2022 | 24.20 Mn |
| Jun 30, 2022 | 26.80 Mn |
| Mar 31, 2022 | 17.00 Mn |
| Dec 31, 2021 | 14.90 Mn |
| Sep 30, 2021 | 15.40 Mn |